Case Studies

22 Apr 2021 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

AI platform improving health outcomes for patients with chronic illness in rural South Australia

A digital platform that uses artificial intelligence for chronic disease clinical decision support is bringing a new model of care to cardiac patients in rural areas.

26 Mar 2021 / Biotechnology / BMTH program / Companies / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Silk-based implants set to revolutionise the treatment of chronic middle ear disease

An innovative, Australian-developed device for the treatment of perforated eardrums has the potential to improve thousands of lives.

26 Feb 2021 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Connecting the Australian Medical Devices Sector to Fast-Track New Technology

What began as an ideas incubator for the South Australian medtech sector has expanded nationally - setting a new benchmark for the translation of medical device technology in Australia.

10 Dec 2020 / Biotechnology / BMTH program / Companies / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Artrya Is On The Pulse

Artificial Intelligence (AI) is changing the face of healthcare, and Artrya wants to redefine how the risk of heart disease is detected in patients.

05 Nov 2020 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Changing Lives with Digital Patient Registry and Analytics Platforms

The Trial Ready Registry Framework (TRRF) project co-funded by MTPConnect Project Fund Program and Queensland University of Technology (QUT), set out to develop a single digital trial ready registry platform to better collect and analyse health data.

07 Oct 2020 / Biotechnology / BMTH program / Companies / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Driving Australia's Medtech Manufacturing for Patients Recovering from Brain Surgery

In 2019, Anatomics saw an opportunity to turn an abandoned car manufacturing facility in Melbourne into an expansive 3D bioprinting warehouse.

29 Jul 2020 / Biotechnology / BMTH program / Companies / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

OncoRes Medical Helps Get Surgeons in Touch

OncoRes Medical was founded at the intersection of medicine, science and humanity by leading clinicians and researchers from the University of Western Australia, the Harry Perkins Institute of Medical Research, and the Western Australian Department of Health.

28 Jul 2020 / Biotechnology / BTB program / Companies / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Let's Hear It For Noisy Guts

Noisy Guts is an emerging early-stage WA medtech start-up that has been awarded $1 million matched funding in Round 1 of MTPConnec's Biomedical Translation Bridge Program.

12 May 2020 / Biotechnology / BMTH program / Companies / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Australia's AxceldaPen: Developing 3D Bioprinting for Stem Cell Repair in Surgery

According to research from Arthritis Australia, the number of people with osteoarthritis and damaged cartilage in Australia is expected to increase nationally from almost 2.2 million in 2015 to almost 3.1 million Australians in 2030[1].

01 May 2020 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Clinical Manufacturing Training Hub Accelerates Research Translation

A clinical manufacturing training hub set up by The Translational Research Institute (TRI), in collaboration with VAXXAS, PharmOut & Eurofins AMS is enabling the translation of innovative, investigational products into clinical studies.

31 Mar 2020 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Reducing Barriers Through Providing Affordable Technical Services to Medtech Companies

Microscopy Australia, through the MTPConnect Project Fund Program, set out to provide easy and discounted access to its microscopy services for medtech R&D companies, by funding up to 200 technical vouchers to reduce existing barriers to use.

25 Feb 2020 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Patient Access is Key for Rural Clinical Trials

The Clinical Oncology Society of Australia (COSA) are bringing access to clinical trials for patients living in rural areas, with support from a funding consortium of industry, Medicines Australia, research institutes and consumer groups.

20 Jan 2020 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Opening Up International Markets: Helping Businesses Expand to India and Indonesia

International markets can be difficult to access for Australian MTP sector companies, with a number of challenges to entry. As part of the MTPConnect Project Fund Program, an Asialink Business project commenced in 2019 to identify opportunities for Australian companies to access global markets.

22 Nov 2019 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

Bridging the Biologics Gap in Thailand

The National Biologics Training Program - born out of The University of Queensland - has set up an international collaboration with Thailand's Centre of Excellence for Life Sciences (TCELS) to provide its biopharmaceutical researchers with professional development training to strengthen capabilities in Biologics R&D, advanced biomanufacturing and global regulation.

30 Oct 2019 / Biotechnology / Companies / GC Program / Investors / Medical Technology / Pharmaceuticals / Researchers / Services

CRITERIA: to improve job-readiness for MTP graduates

Australia has a strong and flourishing clinical trials environment, which makes it an attractive destination to conduct trials.